Colombia Blood Grouping Reagents Market By End User
Colombia Blood Grouping Reagents Market By Technique
By Technique, the market is segmented into PCR-based and Microarray Techniques, Assay-based Techniques, Massively Parallel Sequencing Techniques, Serology, Point of Care Techniques, and Other Techniques (2018-2030)
| Label | PCR-based and Microarray Techniques | Assay-based Techniques | Massively Parallel Sequencing Techniques | Serology | Point of Care Techniques | Other Techniques |
|---|---|---|---|---|---|---|
| 2018 | 1.88 USD Mn | 3.74 USD Mn | 1.54 USD Mn | 6.23 USD Mn | 2.96 USD Mn | 3.2 USD Mn |
| 2019 | 2.09 USD Mn | 4.02 USD Mn | 1.69 USD Mn | 6.62 USD Mn | 3.16 USD Mn | 3.38 USD Mn |
| 2020 | 2.23 USD Mn | 4.16 USD Mn | 1.77 USD Mn | 6.75 USD Mn | 3.25 USD Mn | 3.43 USD Mn |
| 2021 | 2.48 USD Mn | 4.5 USD Mn | 1.95 USD Mn | 7.22 USD Mn | 3.49 USD Mn | 3.64 USD Mn |
| 2022 | 2.78 USD Mn | 4.88 USD Mn | 2.15 USD Mn | 7.73 USD Mn | 3.77 USD Mn | 3.86 USD Mn |
| 2023 | 3.09 USD Mn | 5.29 USD Mn | 2.37 USD Mn | 8.29 USD Mn | 4.07 USD Mn | 4.12 USD Mn |
| 2024 | 3.45 USD Mn | 5.76 USD Mn | 2.62 USD Mn | 8.91 USD Mn | 4.41 USD Mn | 4.41 USD Mn |
| 2025 | 3.86 USD Mn | 6.28 USD Mn | 2.9 USD Mn | 9.59 USD Mn | 4.78 USD Mn | 4.73 USD Mn |
| 2026 | 4.32 USD Mn | 6.87 USD Mn | 3.21 USD Mn | 10.35 USD Mn | 5.19 USD Mn | 5.07 USD Mn |
| 2027 | 4.85 USD Mn | 7.52 USD Mn | 3.57 USD Mn | 11.2 USD Mn | 5.66 USD Mn | 5.44 USD Mn |
| 2028 | 5.46 USD Mn | 8.26 USD Mn | 3.98 USD Mn | 12.14 USD Mn | 6.18 USD Mn | 5.84 USD Mn |
| 2029 | 6.16 USD Mn | 9.09 USD Mn | 4.44 USD Mn | 13.2 USD Mn | 6.77 USD Mn | 6.28 USD Mn |
| 2030 | 6.96 USD Mn | 10.03 USD Mn | 4.98 USD Mn | 14.38 USD Mn | 7.43 USD Mn | 6.76 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The Colombia Blood Grouping Reagents Market By Technique market is on a steady long-term growth path. Segment value stands at roughly USD 35 Mn in 2026 and is projected to reach USD 51 Mn by 2030 — a gain of about 44% over the forecast period, translating to a CAGR in the high single digits.
- Colombia's blood grouping reagents market is seeing an increase in demand, with a growing emphasis on using advanced techniques for accurate results. Blood grouping reagents are substances used to determine a person's blood type and compatibility for blood transfusions or organ transplants.
- What the regional split looks like (2026): Serology leads, holding roughly 30% of segment value — the single largest regional share. Assay-based Techniques is the second-largest contributor. Point of Care Techniques, Other Techniques, PCR-based and Microarray Techniques and Massively Parallel Sequencing Techniques make up the remainder, in descending order.
- By 2030, Serology alone is expected to reach USD 14 Mn, with Assay-based Techniques at USD 10 Mn.
Market Dynamics
Colombia's blood grouping reagents market is seeing an increase in demand, with a growing emphasis on using advanced techniques for accurate results. Blood grouping reagents are substances used to determine a person's blood type and compatibility for blood transfusions or organ transplants. With the rise in chronic diseases and surgeries, the demand for blood grouping tests has also increased. Colombia is no exception to this trend, and the demand for blood grouping reagents in the country is on the rise. One of the key factors contributing to the increasing demand for blood grouping reagents in Colombia is the use of advanced techniques. Different blood grouping techniques, such as serological and molecular methods, are used to accurately determine a person's blood type. Serological techniques, such as the ABO and Rh systems, have been widely used in the past. However, with advancements in technology, molecular techniques, such as PCR and DNA sequencing, are now being used for more precise and reliable results. These advanced techniques are gaining popularity in Colombia, leading to higher demand for reagents used in these methods. Moreover, there is a growing awareness among healthcare professionals and individuals regarding the importance of blood typing before undergoing any medical procedure.
Blood transfusions and organ transplants require strict compatibility between the donor and recipient's blood type. Failure to match blood types can result in severe complications or even death. As a result, healthcare facilities in Colombia are increasingly emphasizing blood grouping tests, which, in turn, is driving the demand for reagents. Another factor contributing to the demand for blood grouping reagents is the increasing prevalence of chronic diseases, such as cancer and cardiovascular diseases, in Colombia. These diseases often require blood transfusions, making it essential to have a steady supply of blood and accurate blood typing results to ensure patients' safety. This has led to a rise in the number of blood banks and blood collection centers in the country, further increasing the demand for blood grouping reagents. In conclusion, the demand for blood grouping reagents in Colombia is expected to continue to grow due to the use of advanced techniques, the increasing awareness regarding the importance of blood typing, and the rise in chronic diseases. It is crucial for healthcare facilities to invest in high-quality blood grouping reagents to ensure accurate results and improve patient outcomes.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2024.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



